Zachary A. Rubnitz
No Rating Available
(Learn About Our Rating System)

Zachary A. Rubnitz, MD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

General Internal Medicine, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-581-7818
Get Directions

Craig H. Neilsen Rehabilitation Hospital

General Internal Medicine
85 N Medical Drive
Salt Lake City , UT 84132
801-581-7818
Get Directions

Huntsman Cancer Institute - Cancer Hospital South

General Internal Medicine
1950 Circle of Hope
Salt Lake City , UT 84112
801-585-0100
Get Directions
Show 1 more location(s)

Huntsman Mental Health Institute

General Internal Medicine
501 Chipeta Way
Salt Lake City , UT 84108
801-583-2500
Get Directions

  • Specialties

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Internal Medicine)

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions General Medicine
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Residency Internal Medicine - University of Utah Spencer Fox Eccles School of Medicine Resident
    Professional Medical Medicine - University of Tennessee Health Science Center, College of Medicine M.D.
    Undergraduate Major: Biological Sciences; Concentrations in Psychology and Global Health - Northwestern University B.A.

    Selected Publications

    Journal Article

    1. Wolf J, Rubnitz Z, Agulnik A, Ferrolino J, Sun Y, Tang L (2024). Phoenix Sepsis Score and Risk of Attributable Mortality in Children With Cancer. JAMA Netw Open, 7(6), e2415917. (Read full publication)
    2. Rubnitz Z, Sun Y, Agulnik A, Merritt P, Allison K, Ferrolino J, Dallas R, Tang L, Wolf J (2023). Prediction of attributable mortality in pediatric patients with cancer admitted to the intensive care unit for suspected infection: A comprehensive evaluation of risk scores. Cancer Med, 12(23), 21287-21292. (Read full publication)
    3. Rubnitz ZA, Kunkel VN, Baselski VS, Summers NA (2022). A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam. Cureus, 14(9), e28855. (Read full publication)